变革的代理人:定量临床药理学和转化科学的人工智能工作流程

IF 3.1 3区 医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL
Mohamed H. Shahin, Srijib Goswami, Sebastian Lobentanzer, Brian W. Corrigan
{"title":"变革的代理人:定量临床药理学和转化科学的人工智能工作流程","authors":"Mohamed H. Shahin,&nbsp;Srijib Goswami,&nbsp;Sebastian Lobentanzer,&nbsp;Brian W. Corrigan","doi":"10.1111/cts.70188","DOIUrl":null,"url":null,"abstract":"<p>Artificial intelligence (AI) is making a significant impact across various industries, including healthcare, where it is driving innovation and increasing efficiency. In the fields of Quantitative Clinical Pharmacology (QCP) and Translational Sciences (TS), AI offers the potential to transform traditional practices through the use of agentic workflows—systems with different levels of autonomy where specialized AI agents work together to perform complex tasks, while keeping “human in the loop.” These workflows can simplify processes, such as data collection, analysis, modeling, and simulation, leading to greater efficiency and consistency. This review explores how these AI-powered agentic workflows can help in addressing some of the current challenges in QCP and TS by streamlining pharmacokinetic and pharmacodynamic analyses, optimizing clinical trial designs, and advancing precision medicine. By integrating domain-specific tools while maintaining data privacy and regulatory standards, well-designed agentic workflows empower scientists to automate routine tasks and make more informed decisions. Herein, we showcase practical examples of AI agents in existing platforms that support QCP and biomedical research and offer recommendations for overcoming potential challenges involved in implementing these innovative workflows. Looking ahead, fostering collaborative efforts, embracing open-source initiatives, and establishing robust regulatory frameworks will be key to unlocking the full potential of agentic workflows in advancing QCP and TS. These efforts hold the promise of speeding up research outcomes and improving the efficiency of drug development and patient care.</p>","PeriodicalId":50610,"journal":{"name":"Cts-Clinical and Translational Science","volume":"18 3","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2025-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/cts.70188","citationCount":"0","resultStr":"{\"title\":\"Agents for Change: Artificial Intelligent Workflows for Quantitative Clinical Pharmacology and Translational Sciences\",\"authors\":\"Mohamed H. Shahin,&nbsp;Srijib Goswami,&nbsp;Sebastian Lobentanzer,&nbsp;Brian W. Corrigan\",\"doi\":\"10.1111/cts.70188\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Artificial intelligence (AI) is making a significant impact across various industries, including healthcare, where it is driving innovation and increasing efficiency. In the fields of Quantitative Clinical Pharmacology (QCP) and Translational Sciences (TS), AI offers the potential to transform traditional practices through the use of agentic workflows—systems with different levels of autonomy where specialized AI agents work together to perform complex tasks, while keeping “human in the loop.” These workflows can simplify processes, such as data collection, analysis, modeling, and simulation, leading to greater efficiency and consistency. This review explores how these AI-powered agentic workflows can help in addressing some of the current challenges in QCP and TS by streamlining pharmacokinetic and pharmacodynamic analyses, optimizing clinical trial designs, and advancing precision medicine. By integrating domain-specific tools while maintaining data privacy and regulatory standards, well-designed agentic workflows empower scientists to automate routine tasks and make more informed decisions. Herein, we showcase practical examples of AI agents in existing platforms that support QCP and biomedical research and offer recommendations for overcoming potential challenges involved in implementing these innovative workflows. Looking ahead, fostering collaborative efforts, embracing open-source initiatives, and establishing robust regulatory frameworks will be key to unlocking the full potential of agentic workflows in advancing QCP and TS. These efforts hold the promise of speeding up research outcomes and improving the efficiency of drug development and patient care.</p>\",\"PeriodicalId\":50610,\"journal\":{\"name\":\"Cts-Clinical and Translational Science\",\"volume\":\"18 3\",\"pages\":\"\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2025-03-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/cts.70188\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cts-Clinical and Translational Science\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/cts.70188\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cts-Clinical and Translational Science","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/cts.70188","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

摘要

人工智能(AI)正在对包括医疗保健在内的各行各业产生重大影响,推动创新并提高效率。在定量临床药理学(QCP)和转化科学(TS)领域,人工智能通过使用代理工作流(具有不同自主程度的系统,其中专门的人工智能代理共同执行复杂的任务,同时保持 "人在回路中"),为改变传统做法提供了潜力。这些工作流程可以简化数据收集、分析、建模和模拟等流程,从而提高效率和一致性。本综述探讨了这些人工智能驱动的代理工作流如何通过简化药代动力学和药效学分析、优化临床试验设计和推进精准医疗,帮助解决 QCP 和 TS 领域当前面临的一些挑战。通过整合特定领域的工具,同时维护数据隐私和监管标准,设计良好的代理工作流能使科学家自动完成常规任务,并做出更明智的决策。在此,我们将展示支持 QCP 和生物医学研究的现有平台中的人工智能代理实例,并就如何克服实施这些创新工作流程过程中可能遇到的挑战提出建议。展望未来,促进合作、接受开源倡议和建立健全的监管框架将是释放代理工作流在推进 QCP 和 TS 方面全部潜力的关键。这些努力有望加快研究成果的取得,并提高药物开发和患者护理的效率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Agents for Change: Artificial Intelligent Workflows for Quantitative Clinical Pharmacology and Translational Sciences

Agents for Change: Artificial Intelligent Workflows for Quantitative Clinical Pharmacology and Translational Sciences

Artificial intelligence (AI) is making a significant impact across various industries, including healthcare, where it is driving innovation and increasing efficiency. In the fields of Quantitative Clinical Pharmacology (QCP) and Translational Sciences (TS), AI offers the potential to transform traditional practices through the use of agentic workflows—systems with different levels of autonomy where specialized AI agents work together to perform complex tasks, while keeping “human in the loop.” These workflows can simplify processes, such as data collection, analysis, modeling, and simulation, leading to greater efficiency and consistency. This review explores how these AI-powered agentic workflows can help in addressing some of the current challenges in QCP and TS by streamlining pharmacokinetic and pharmacodynamic analyses, optimizing clinical trial designs, and advancing precision medicine. By integrating domain-specific tools while maintaining data privacy and regulatory standards, well-designed agentic workflows empower scientists to automate routine tasks and make more informed decisions. Herein, we showcase practical examples of AI agents in existing platforms that support QCP and biomedical research and offer recommendations for overcoming potential challenges involved in implementing these innovative workflows. Looking ahead, fostering collaborative efforts, embracing open-source initiatives, and establishing robust regulatory frameworks will be key to unlocking the full potential of agentic workflows in advancing QCP and TS. These efforts hold the promise of speeding up research outcomes and improving the efficiency of drug development and patient care.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Cts-Clinical and Translational Science
Cts-Clinical and Translational Science 医学-医学:研究与实验
CiteScore
6.70
自引率
2.60%
发文量
234
审稿时长
6-12 weeks
期刊介绍: Clinical and Translational Science (CTS), an official journal of the American Society for Clinical Pharmacology and Therapeutics, highlights original translational medicine research that helps bridge laboratory discoveries with the diagnosis and treatment of human disease. Translational medicine is a multi-faceted discipline with a focus on translational therapeutics. In a broad sense, translational medicine bridges across the discovery, development, regulation, and utilization spectrum. Research may appear as Full Articles, Brief Reports, Commentaries, Phase Forwards (clinical trials), Reviews, or Tutorials. CTS also includes invited didactic content that covers the connections between clinical pharmacology and translational medicine. Best-in-class methodologies and best practices are also welcomed as Tutorials. These additional features provide context for research articles and facilitate understanding for a wide array of individuals interested in clinical and translational science. CTS welcomes high quality, scientifically sound, original manuscripts focused on clinical pharmacology and translational science, including animal, in vitro, in silico, and clinical studies supporting the breadth of drug discovery, development, regulation and clinical use of both traditional drugs and innovative modalities.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信